Balchem Corporation (BCPC) Stock Price

BCPCStock

$178.44+10.15%52W

Market Cap$5.69B

P/E36.91x

PEG Ratio3.59

Div yield0.58%

Beta0.86

BCPC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-12.00%

Price vs S&P 500 (4W)1.26%

PEG Ratio3.59

VGM Score53.09

P/E Ratio (Annual)36.91x

Indicated Dividend Yield (Annual)0.58%

P/CF (Annual)26.39x

Book Value / Share (Quarterly)$40.76

P/TBV (Annual)4.54x

Indicated Dividend (Annual)$0.96

Revenue Growth (3Y)3.25%

Cash Flow / Share (Quarterly)$5.36

Payout Ratio (TTM)18.73%

Price vs S&P 500 (YTD)3.53%

Gross Margin (TTM)36.29%

Net Profit Margin (TTM)15.14%

EPS (TTM)$5.08

10-Day Avg Trading Volume0.16M

EPS Excl Extra (TTM)$5.08

Revenue Growth (5Y)8.07%

EPS (Annual)$4.75

Dividend / Share (Annual)$0.88

ROI (Annual)10.88%

Gross Margin (Annual)35.74%

Net Profit Margin (5Y Avg)12.68%

Cash / Share (Quarterly)$1.98

P/E Basic Excl Extra (TTM)34.76x

Revenue Growth QoQ (YoY)11.17%

EPS Growth (5Y)12.78%

P/E Normalized (Annual)36.91x

ROA (Last FY)9.18%

Revenue Growth TTM (YoY)10.14%

EBITD / Share (TTM)$8.34

ROE (5Y Avg)11.19%

Operating Margin (TTM)20.42%

Cash Flow / Share (Annual)$5.40

P/B Ratio4.39x

P/B Ratio (Quarterly)4.17x

Net Income / Employee (Annual)$113,200

EV / Revenue (TTM)5.35x

Net Interest Coverage (TTM)19.58x

ROA (TTM)9.77%

EPS Growth QoQ (YoY)18.31%

EV / EBITDA (TTM)21.53x

EPS Incl Extra (Annual)$4.75

Current Ratio (Annual)2.07x

Quick Ratio (Quarterly)1.49x

3-Month Avg Trading Volume0.21M

52-Week Price Return10.15%

EV / Free Cash Flow (Annual)33.55x

P/E Incl Extra (TTM)34.76x

Revenue / Employee (TTM)$793,800

Tangible BV / Share (Quarterly)$36.01

P/S Ratio (Annual)5.51x

Asset Turnover (Annual)0.62x

52-Week High$183.90

Operating Margin (5Y Avg)17.60%

EPS Excl Extra (Annual)$4.75

CapEx CAGR (5Y)5.17%

Tangible BV CAGR (5Y)9.14%

26-Week Price Return-0.07%

Quick Ratio (Annual)1.27x

13-Week Price Return11.34%

Total Debt / Equity (Annual)0.13x

Current Ratio (Quarterly)2.66x

Enterprise Value$5.81B

Revenue / Share Growth (5Y)8.00%

Asset Turnover (TTM)0.65x

Book Value / Share Growth (5Y)8.94%

Revenue / Employee (Annual)$758,200

Inventory Turnover (Annual)5.08x

Pretax Margin (Annual)19.19%

Cash / Share (Annual)$2.33

3-Month Return Std Dev19.25%

Gross Margin (5Y Avg)32.79%

Net Income / Employee (TTM)$120,200

EBITDA CAGR (5Y)9.45%

EBITDA Interim CAGR (5Y)10.84%

ROE (Last FY)12.31%

Net Interest Coverage (Annual)24.15x

EPS Basic Excl Extra (Annual)$4.75

P/FCF (TTM)33.35x

Receivables Turnover (TTM)7.62x

EV / Free Cash Flow (TTM)33.88x

Total Debt / Equity (Quarterly)0.12x

EPS Incl Extra (TTM)$5.08

Receivables Turnover (Annual)7.88x

ROI (TTM)11.36%

Dividend Growth Rate (5Y)11.12%

P/S Ratio (TTM)5.26x

Pretax Margin (5Y Avg)16.28%

Revenue / Share (Annual)$31.81

Tangible BV / Share (Annual)$34.13

Forward P/E27.46x

Free OCF CAGR (5Y)8.20%

Price vs S&P 500 (52W)-8.40%

P/E Ratio (TTM)34.76x

EPS Growth TTM (YoY)16.69%

Year-to-Date Return16.35%

5-Day Price Return0.53%

EPS Normalized (Annual)$4.75

ROA (5Y Avg)7.73%

Net Profit Margin (Annual)14.93%

Month-to-Date Return6.50%

Cash Flow / Share (TTM)$4.87

EBITD / Share (Annual)$7.82

EPS Growth (3Y)13.44%

Operating Margin (Annual)20.18%

LT Debt / Equity (Annual)0.13x

P/CF (TTM)26.03x

ROI (5Y Avg)9.15%

P/E Excl Extra (TTM)34.76x

LT Debt / Equity (Quarterly)0.12x

EPS Basic Excl Extra (TTM)$5.08

P/TBV (Quarterly)4.72x

Payout Ratio (Annual)18.27%

P/B Ratio (Annual)3.95x

Dividend / Share (TTM)$0.96

Inventory Turnover (TTM)4.47x

Pretax Margin (TTM)19.56%

Book Value / Share (Annual)$39.22

Price vs S&P 500 (13W)9.39%

Net Margin Growth (5Y)4.43%

Dividend Yield (TTM)0.54%

Beta0.86x

P/FCF (Annual)33.03x

Revenue / Share (TTM)$33.72

ROE (TTM)12.79%

52-Week Low$139.17

vGradeD

gGradeB

mGradeB

vgmGradeC

BCPC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 31, 2026	$1.43	$1.49	+4.56%(+$0.06)
Q1 2026	Apr 30, 2026	$1.33	$1.33	+0.00%(+$0.00)
Q4 2025	Feb 20, 2026	$1.28	$1.31	+1.95%(+$0.03)
Q3 2025	Oct 21, 2025	$1.31	$1.35	+3.05%(+$0.04)
Q2 2025	Jul 31, 2025	$1.25	$1.27	+1.60%(+$0.02)

BCPC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Chemicals(15)

Symbol	Value Score	Growth Score	Momentum Score	Price
BCPCBalchem Corporation	D	B	B	$178.44
SOLSSolstice Advanced Materials Inc. Common Stock	C	D	D	$63.53
PRMPerimeter Solutions, Inc.	D	B	C	$30.62
NGVTIngevity Corporation	C	C	C	$69.43
CCThe Chemours Company	B	D	C	$15.62
IOSPInnospec Inc.	C	B	B	$95.38
OLNOlin Corp.	A	C	D	$17.15
HUNHuntsman Corporation	A	C	D	$9.47
FMCFMC Corporation	A	D	D	$11.33
ECVTEcovyst Inc.	B	C	C	$10.11
SLIStandard Lithium Ltd.	—	—	D	$2.55
ADURAduro Clean Technologies Inc. Common Stock	F	B	C	$14.17
ACNTAscent Industries Co. Common Stock	B	F	B	$15.43
CITRCitroTech Inc.	F	A	D	$6.09
LOOPLoop Industries, Inc. Common Stock	F	F	F	$0.52
GUREGulf Resources, Inc. (NV) Common Stock	A	B	C	$3.90

About Balchem Corporation

Balchem manufactures specialty performance ingredients using proprietary microencapsulation and chelation technologies. The company operates three business segments—Human Nutrition and Health (its largest), Animal Nutrition and Health, and Specialty Products—offering choline-based nutrients, mineral amino acid chelates, and specialty chemicals to diverse end markets. Balchem generates the majority of its revenue in the United States, with additional international sales.